EPIDEMIOLOGY, ETIOLOGY AND PREVENTION OF GENITAL PROLAPSE: REVIEW.
Introduction: Improving the system for correcting pelvic floor dysfunction (urinary incontinence and fecal incontinence in combination with pelvic organ prolapse) is one of the most pressing modern socially significant and medical problems today. This nosology is a global health problem that affects millions of women around the world. The massive cost of pelvic disorders to health systems and society is enormous. About one in five women will have surgery for genital prolapse or urinary incontinence by age 85
Aim: to review the prevalence, etiology and prevention of genital prolapse according to research.
Search strategy: We studied publicly available articles over 10 years using the following databases of scientific publications and specialized search engines: PubMed, Mendeley, Scopus, Web of Science, Google Scholar. Inclusion criteria: Publication level of evidence A, B: meta-analyzes, systematic reviews, cohort and cross-sectional studies. Exclusion criteria: expert opinion in the form of short messages, promotional articles
Findings and Conclusion: The prevalence of prolapse varied widely from 10-64% to an average of 25%. However, data on the prevalence of different departments of prolapse are somewhat contradictory. Since we do not have a single standardized diagnostic approach. The prevalence of prolapse increases with age according to published research data. Old age is an established factor in prolapse. 50 years is the most common age for prolapse. A predisposing risk factor is a congenital weakness of the connective tissue due to a genetic mutation that is unchanged. We can provide prevention for other factors such as obesity and overweight, menopause, parity, mode of delivery, constipation, diseases with prolonged cough, heavy physical work. Increasing life expectancy and the increasing number of obese women increase the risk of pelvic prolapse spread in the future. We do not have resolved issues of prevention today, this actualizes our study. The research results give us hope for effective prevention and conservative treatment with pelvic floor muscle exercises combined with physiotherapy.
Mariya V. Laktionova1, https://orcid.org/0000-0002-9435-8841
Altyn M. Aringazina²,https://orcid.org/0000-0002-9056-2394
Maksut K. Kulzhanov¹, https://orcid.org/0000-0002-9701-4016
Mairash A. Baimuratova1, https://orcid.org/0000-0003-0219-7874
Arsen А. Askerov3, https://orcid.org/0000-0003-4447-9650
Zaituna G. Khamidullina4, https://orcid.org/0000-0002-5324-8486
1 Kazakhstan’s Medical University «Kazakhstan School of Public Health», Almaty, the Republic of Kazakhstan;
² Caspian International School of Medicine, Almaty, the Republic of Kazakhstan;
3 Kyrgyz-Russian Slavic University named of B.N. Yeltsin, Bishkek, Kyrgyz Republic.
4 NJSC «Astana Medical University», Astana, Republic of Kazakhstan.
1. Журалев А.В. Оптимизация способов хирургического лечения ректоцеле и геморроя. Диссертация на соискание ученой степени кандидата медицинских наук. 2010. 165с.
2. Ищенко А.И., Шульчина И.В., Ищенко А.А. и др. Mesh-ассоциированные осложнения. Факторы риска // Архив акушерства и гинекологии им. В.Ф. Снегирева. 2014. Т.1, №2. С. 4-7.
3. Куликов А., Пересада О.А., Соловей С.В., Котова Г.С. Возможности консервативного лечения пролапса тазовых органов у женщин // Охрана материнства и детства. 2016. № 2 (28). С. 58-63.
4. Лоран О.Б. Эпидемиология, этиология, патогенез, диагностика недержания мочи // Урология. 2001. №2. С.11 – 21.
5. Almousa S., Bandin van Loon A. The prevalence of urinary incontinence in nulliparous adolescent and middle-aged women and the associated risk factors: A systematic review // Maturitas. 2018. №107. P.78
6. Barca J.A. et al. Pelvic floor morbidity following vaginal delivery versus cesarean delivery: Systematic review and meta-analysis // J. Clin. Med. 2021. Vol.10, №8. P. 1–14.
7. Barber M.D., Neubauer N.L., Klein-Olarte V. Can we screen for pelvic organ prolapse without a physical examination in epidemiologic studies? // Am J Obstet Gynecol. 2006 Oct, 195(4):942-8. doi: 10.1016/j.ajog.2006.02.050. Epub 2006 May 8. PMID: 16681989.
8. Boyle R., Hay-Smith E.J., Cody J.D., Mørkved S. Pelvic floor muscle training for prevention and treatment of urinary and fecal incontinence in antenatal and postnatal women: a short version Cochrane review // Neurourol Urodyn. 2014 Mar, 33(3):269-76. doi: 10.1002/nau.22402. Epub 2013 Apr 24. PMID: 23616292.
9. Citak N. et al. Postpartum sexual function of women and the effects of early pelvic floor muscle exercises // Acta Obstet. Gynecol. Scand. Wiley Online Library, 2010. Vol. 89, № 6. P. 817–822.
10. Dumoulin C., Cacciari L.P., Hay‐Smith E.J.C. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women // Cochrane database Syst. Rev. John Wiley & Sons, Ltd, 2018. № 10.
11. Dekker J.H. Pelvic organ prolapse: prevention by training? // Lancet. 2017. № 389 (10067). P. 336-337.
12. Dumoulin C., Cacciari L.P., Hay-Smith E.J.C. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women // Cochrane Database Syst Rev. 2018 Oct 4. 10(10):CD005654. doi: 10.1002/14651858.CD005654.pub4. PMID: 30288727; PMCID: PMC6516955.
13. Giri A. et al. Obesity and pelvic organ prolapse: a systematic review and meta-analysis of observational studies // J. Obstet. Gynecol. Elsevier, 2017. Vol.217, №1. P.11-26.e3.
14. Farrell S.A., Allen V.M., Baskett T.F Parturition and urinary incontinence in primiparas / // Obstet Gynecol. 2001. № 97. P.350–356.,
15. Goran Talic et al. Varicose veins and uterine prolapse in female patients treated foe idiopathic scoliosis // Angew. Chemie Int. Ed. 6(11), 951–952. 1967. P. 5–24.
16. Gallas S. et al. Prevalence and risk factors for urinary and anal incontinence in Tunisian middle aged women // African J. Urol. Pan African Urological Surgeons’ Association., 2018. Vol. 24, № 4. P. 368–373.
17. Hage-Fransen M.A.H. et al. Pregnancy- and obstetric - related risk factors for urinary incontinence, fecal incontinence, or pelvic organ prolapse later in life: A systematic review and meta-analysis // Acta Obstet. Gynecol. Scand. John Wiley & Sons, Ltd, 2021. Vol. 100, № 3. P. 373–382.
18. Hannestad Y.S., Rortveit G., Sandvik H. et al. A community-based epidemiological survey of female urinary incontinence: the Norwegian EPINCONT study. Epidemiology of Incontinence in the County of Nord-Trondelag // J Clin Epidemiol. 2000. №53. P.1150–115
19. Islam R.M., Oldroyd J., Rana J., Romero L., Karim M.N. Prevalence of symptomatic pelvic floor disorders in community-dwelling women in low and middle-income countries: a systematic review and meta-analysis // Int Urogynecol J. 2019 Dec. 30(12):2001-2011. doi: 10.1007/s00192-019-03992-z. Epub 2019 Jun 4. PMID: 31165221. https://pubmed.ncbi.nlm.nih.gov/31165221/
20. Jokhio A.H., Rizvi R.M., MacArthur C. Prevalence of pelvic organ prolapse in women, associated factors and impact on quality of life in rural Pakistan: Population-based study // BMC Womens. Health. 2020. Vol. 20, № 1. P. 1–14.
21. Kolberg Tennfjord M. et al. Effect of postpartum pelvic floor muscle training on vaginal symptoms and sexual dysfunction—secondary analysis of a randomised trial // BJOG An Int. J. Obstet. Gynaecol. Wiley Online Library, 2016. Vol. 123, № 4. P. 634–642.
22. Li Z. et al. An epidemiologic study of pelvic organ prolapse in postmenopausal women: a population-based sample in China // Climacteric. Taylor & Francis, 2019. Vol. 22, № 1. P. 79–84.
23. Milsom I., Gyhagen M. Breaking news in the prediction of pelvic floor disorders // Best Pract. Res. Clin. Obstet. Gynaecol. Baillière Tindall, 2019. Vol. 54. P. 41–48.
24. Masenga G.G., Shayo B.C., Rasch V. Prevalence and risk factors for pelvic organ prolapse in Kilimanjaro, Tanzania: A population based study in Tanzanian rural community // PLoS One. 2018. Vol. 13, № 4. P. 1–13.
25. Ouyang Y. et al. Safety and efficacy of a self-developed Chinese pelvic repair system and Avaulta repair system for the treatment of pelvic organ prolapse in women: A multicenter, prospective, randomized, parallel-group study // Medicine (Baltimore). 2020. Vol. 99, № 38. P. e22332.
26. Ojiyi E.C. et al. Uterovaginal prolapse at a university teaching hospital in south-East Nigeria // Orient J. Med. 2013. Vol. 25, № 3–4. P. 107–112.
27. Romeikienė K.E., Bartkevičienė D. Pelvic-floor dysfunction prevention in prepartum and postpartum periods // Med. 2021. Vol. 57, № 4.
28. Shrestha B. et al. Women’s experiences and health care-seeking practices in relation to uterine prolapse in a hill district of Nepal // BMC Womens. Health. Springer, 2014. Vol. 14, № 1. P. 1–9.
29. Scherf C. et al. Epidemiology of pelvic organ prolapse in rural Gambia, West Africa // BJOG an Int. J. Obstet. Gynaecol. Elsevier, 2002. Vol. 109, № 4. P. 431–436.
30. Schreiber Pedersen L. [et al.] Prevalence of urinary incontinence among women an analysis of potential risk factors in Germany and Denmark // Acta Obstet Gynecol Scand. 2017. №96(8). P.939–948.].
31. Yuk J.S. et al. The prevalence and treatment pattern of clinically diagnosed pelvic organ prolapse: A Korean National Health Insurance Database-based cross-sectional study 2009-2015 // Sci. Rep. Springer US, 2018. Vol. 8, № 1. P. 4–9.
32. Yang X., Zhang A., Sayer L., Bassett S., Woodward S. The effectiveness of group-based pelvic floor muscle training in preventing and treating urinary incontinence for antenatal and postnatal women: a systematic review // Int Urogynecol J. 2021 Aug 28. doi: 10.1007/s00192-021-04960-2. Epub ahead of print. PMID: 3445355
33. Veit-Rubin N. et al. Association between joint hypermobility and pelvic organ prolapse in women: a systematic review and meta-analysis // Int. Urogynecol. J. 2016. Vol. 27, № 10. P. 1469–1478.
34. Weintraub A.Y., Glinter H., Marcus-Braun N. Narrative review of the epidemiology, diagnosis and pathophysiology of pelvic organ prolapse // Int. Braz J Urol. 2020. Vol. 46, № 1. P. 5–14.
35. Wu J.M. et al. Prevalence and trends of symptomatic pelvic floor disorders in US women // Obstet. Gynecol. NIH Public Access, 2014. Vol. 123, № 1. P. 141.
36. Wusu-Ansah O.K., Opare-Addo H.S. Pelvic organ prolapse in rural Ghana // Int. J. Gynecol. Obstet. Elsevier, 2008. Vol. 103, № 2. P. 121–124.
37. Wu Y.M., McInnes N., Leong Y. Pelvic Floor Muscle Training Versus Watchful Waiting and Pelvic Floor Disorders in Postpartum Women: A Systematic Review and Meta-analysis // Female Pelvic Med Reconstr Surg. 2018 Mar/Apr, 24(2):142-149. doi: 10.1097/SPV.0000000000000513. PMID: 29474288.
38. Zeleke B.M., Bell R.J., Billah B., Davis S.R. Symptomatic pelvic floor disorders in community-dwelling older Australian women // Maturitas. 2016 Mar;85:34-41. https://pubmed.ncbi.nlm.nih.gov/26857877/
References:
1. Zhuralev AV. Optimizatsiya sposobov khirurgicheskogo lecheniya rectotsele i gemorroya. [Optimization of methods of rectocele and hemorrhoids surgical treatment]. Kand dissertatt. [Cand dissert]. Oct 2010. 2010. [in Russian]
2. Ishchenko A.I., Shulchina I.V., Ishchenko A.A. et al. Mesh-assotsiirovanniye oslozhneniya. Factory riska. [Mesh-associated complications. Risk factors] Arkhiv akusherstva i gynecologii im V.F. Snegireva [Archive of Obstetrics and Gynecology Named after V.F. Snegirev] - 2014. Vol. 1, No. 2. P. 4-7. [in Russian]
3. Kulikov A., Peresada O.A., Solovey S.V., Kotova G.S. Vozmozhnosti konservativnogo lecheniya prolapsa tazoviykh organov y zhenshin [Possibilities of female pelvic organ prolapse of conservative treatment]. Okhrana materinstva i detstva. [Maternity and childhood protection]. - 2016. No.2(28). pp. 58-63. [in Russian]
4. Laurent O.B. Epidemiologiya, etiologiya, pathogenes, diagnostika nederzhaniya mochi [Epidemiology, etiology, pathogenesis, diagnosis of urinary incontinence]. Urologiya [Urology]. 2001. No.2. pp.11 – 21. [in Russian]
Number of Views: 63
Category of articles:
Original articles
Bibliography link
Laktionova M.V., Aringazina A.M., Kulzhanov M.K., Baimuratova M.A., Askerov A.A., Khamidullina Z.G. Epidemiology, etiology and prevention of genital prolapse: review // Nauka i Zdravookhranenie [Science & Healthcare]. 2023, (Vol.25) 3, pp. 247-256. doi 10.34689/SH.2023.25.3.031Related publications:
ANALYSIS OF CLINICAL AND DEMOGRAPHIC INDICATORS OF PATIENTS WITH PARKINSON'S DISEASE IN THE SOUTHERN REGION OF KAZAKHSTAN
A COMPARATIVE STUDY OF DRUG POLICY REGARDING ORPHAN DISEASES IN THE USA, THE EUROPEAN UNION, AND THE REPUBLIC OF KAZAKHSTAN
MUTATIONS IN CARDIAC ION CHANNEL GENES IN KAZAKHSTANI PATIENTS WITH LONG QT SYNDROME
GENETIC FEATURES OF CONGENITAL DYSFUNCTION OF THE ADRENAL CORTEX CAUSED BY 21-HYDROXYLASE DEFICIENCY IN PERSONS OF KAZAKH NATIONALITY
NON-MOTOR SYMPTOMS IN PARKINSON'S DISEASE USING THE EXAMPLE OF AKTOBE PATIENTS